FLS

Flowserve

$83.10

-0.67%
Nov 13, 2026
Bobby Quantitative Model
Flowserve Corporation is a manufacturer and aftermarket service provider of precision-engineered flow control systems, producing pumps, valves, mechanical seals, and related automation and replacement parts for the oil and gas, chemical, power generation, and water management end markets through its Flowserve Pumps Division (FPD) and Flow Control Division (FCD). With roughly 16,000 employees and a legacy dating to a 1972 NYSE listing, Flowserve is best characterized as an established, mid-cap industrial compounder whose competitive identity rests on an installed base of engineered-to-order equipment that generates high-margin recurring aftermarket revenue — approximately 56% of the most recent quarter's $1.24 billion in sales came from aftermarket equipment versus 44% from original equipment. The current investor narrative centers on the durability of that aftermarket mix, margin expansion from the company's operational improvement program, and a Q3 2026 print (reported October 28) that delivered an EPS beat of $0.81 against consensus alongside 5.4% year-over-year revenue growth, though mixed divisional performance and a choppy tape have kept the debate balanced. Attention is also focused on capital deployment — a roughly $518 million acquisition in Q2 2026, $50 million of Q3 buybacks, and a modest 1.2% dividend yield — as management balances growth investment against deleveraging and shareholder returns.

People also watch

GE Vernova

GE Vernova

GEV

Analysis
Parker Hannifin

Parker Hannifin

PH

Analysis
Emerson Electric

Emerson Electric

EMR

Analysis
Illinois Tool Works

Illinois Tool Works

ITW

Analysis
Honeywell

Honeywell

HON

Analysis

BobbyInvestment Opinion: Should I buy FLS Today?

Rating: Hold with a constructive bias. The core thesis is that Flowserve's 56% aftermarket mix ($697.5 million of Q3 2026's $1.238 billion in sales) provides durable, high-margin recurring revenue that supports mid-single-digit growth and gradual margin expansion, but at $80.37 the stock already reflects much of that story after a 13.97% one-month rally, leaving only about 13.5% upside to the $91.20 average analyst target. The 7 Buy / 4 Hold / 0 Sell consensus (mean rating 1.82) and post-earnings reaffirmations from Citigroup (Buy) and RBC (Outperform) on October 30 confirm that the professional community sees more to like than fear, but the absence of fresh upgrades and TD Cowen's June 24 downgrade to Hold show the easy money has been made.

Four data points anchor the rating. First, valuation is reasonable but not cheap: 17.3x forward earnings versus roughly 22x for large-cap industrials is a ~20% discount, and the 1.10 PEG suggests growth is fairly priced, while the 26.1x trailing multiple sits near the top of its multi-year band. Second, growth is steady rather than accelerating — Q3 revenue rose 5.39% year-over-year to $1.238 billion, with sequential build from $1.068 billion (Q1) to $1.169 billion (Q2) to $1.238 billion (Q3), and full-year consensus of ~$5.98 billion implies continued mid-single-digit expansion. Third, profitability is solid but the margin trend is mixed: gross margin moved 37.1% → 32.9% → 33.5% across Q1-Q3 2026 and operating margin slipped from 13.6% to 12.5%, so the mid-teens operating margin needed to justify the $100 high target is not yet visible. Fourth, cash conversion is the weak link — TTM free cash flow of $153.7 million on a ~$9.0 billion market cap is a 1.7% FCF yield, and Q1 2026 operating cash flow was -$43.1 million before rebounding to $144.1 million in Q3.

The thesis would upgrade to Buy on either a pullback toward the $75 low target (which would restore ~20% upside to the $91.20 average) or evidence that operating margins are pushing toward the mid-teens with FCF conversion improving above a 3% yield. It would downgrade to Sell if revenue growth decelerates below ~3%, if aftermarket mix slips below 50%, or if the $517.7 million Q2 acquisition integration disappoints and debt-to-equity (currently 0.80) rises further. Net verdict: fairly valued to modestly undervalued relative to peers on a forward basis, but fully valued relative to its own recent trading range — a stock to accumulate on weakness rather than chase after a 14% monthly move.

Sign up to view all

FLS 12-Month Price Forecast

Flowserve is a fairly valued, mid-single-digit-growth industrial whose 56% aftermarket mix and 7 Buy / 0 Sell analyst consensus justify a constructive but not aggressive stance. The 17.3x forward multiple embeds roughly 20% discount to large-cap industrials and a fair 1.10 PEG, yet the 13.5% upside to the $91.20 average target is moderate after a 13.97% one-month rally that has already pushed the stock above the $75 low target. The key swing factor is margin: if operating margin pushes from 12.5% toward the mid-teens and FCF conversion improves from the current 1.7% yield, the path to the $100 high target opens; if margins stall and cash generation stays lumpy, the stock likely trades in the $75-$90 range. I would upgrade to bullish on a pullback toward $75 or on a Q4 print showing operating margin above 13.5% with aftermarket mix intact, and downgrade to bearish if revenue growth falls below 3% or aftermarket mix drops below 50%.

Historical Price
Current Price $83.10
Average Target $90.50
High Target $100.00
Low Target $63.27

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Flowserve's 12-month outlook, with a consensus price target around $91.20 and implied upside of +9.8% versus the current price.

Average Target

$91.20

11 analysts

Implied Upside

+9.8%

vs. current price

Analyst Count

11

covering this stock

Price Range

$75 - $100

Analyst target range

Buy
7 (64%)
Hold
4 (36%)
Sell
0 (0%)

Coverage is moderate with 10 analysts, and sentiment is clearly bullish: 7 Buy ratings, 4 Hold ratings, and zero Sells produce a consensus recommendation of "buy" with a mean rating of 1.82 (where 1.0 is a strong buy). The average target price of $91.20 implies roughly 13.5% upside from the current $80.37, and the consensus 2027 EPS estimate of $6.36 against a $91.20 target implies a target multiple of about 14.3x forward earnings — a modest re-rating from the current 17.3x forward multiple, suggesting analysts expect earnings growth to do the heavy lifting rather than multiple expansion. The bullish tilt is reinforced by recent institutional actions: Citigroup reiterated Buy and RBC Capital reiterated Outperform on October 30 following the Q3 print, Mizuho reiterated Outperform on October 15, and Stifel reiterated Buy on July 31 — a pattern of steady reaffirmation rather than fresh upgrades. The one cautionary note is TD Cowen's June 24 downgrade from Buy to Hold, which shows at least one house has stepped to the sidelines on valuation. The target range of $75.00 to $100.00 is moderately wide — a 33% spread from low to high — signaling meaningful dispersion in assumptions rather than tight consensus. The $100 high target implies roughly 24% upside and would require either multiple expansion toward 16x forward EPS or upside to the $6.36 consensus estimate, likely predicated on continued aftermarket mix improvement, successful integration of the Q2 acquisition, and margin expansion toward the mid-teens operating level. The $75 low target sits about 6.7% below the current price and effectively prices in flat-to-modest earnings delivery with no multiple expansion, or a scenario where oil and gas capex softens and the aftermarket growth engine decelerates. With the stock having already rallied 14% in a month and now trading above the low target, the risk/reward has narrowed; the consensus still points higher, but the 13.5% implied upside to the average target is a moderate rather than compelling return, and the wide $25 spread argues for position sizing discipline given the 1.277 beta.

Drowning in data?

Find the real signal!

Bulls vs Bears: FLS Investment Factors

The bull case currently holds the stronger evidence: a 56% aftermarket mix supports durable revenue, Q3 delivered an $0.81 EPS beat on 5.4% revenue growth with sequential acceleration, and the 17.3x forward multiple sits roughly 20% below the large-cap industrial average with a fair 1.10 PEG. Analyst sentiment reinforces this, with 7 Buys, zero Sells, and a $91.20 average target implying 13.5% upside, backed by post-earnings reaffirmations from Citigroup and RBC. The bear case rests on a thin 1.7% FCF yield, 0.80 debt-to-equity after a $517.7 million acquisition funded partly with $428.6 million of new debt, and a 14% one-month rally that has already pushed the stock above the $75 low target. The single most important tension is whether margin expansion and aftermarket mix improvement can convert into the EPS growth the 17.3x forward multiple requires — if operating margins hold near 12.5% and FCF stays lumpy, the re-rating thesis stalls; if margins push toward the mid-teens, the path to $100 opens.

Bullish

  • Aftermarket mix anchors revenue durability: Aftermarket equipment contributed $697.5 million, or 56%, of Q3 2026's $1.238 billion in sales versus 44% from original equipment. Parts and service carry structurally better economics than lumpy, competitively bid OE projects, so this mix underpins both revenue stability and margin quality through cycles.
  • Q3 beat with steady sequential revenue build: Q3 2026 EPS of $0.81 beat consensus and revenue rose 5.39% year-over-year to $1.238 billion from $1.174 billion. The quarterly progression from $1.068 billion in Q1 to $1.169 billion in Q2 to $1.238 billion in Q3 shows consistent sequential acceleration rather than a one-off print.
  • Forward multiple compresses sharply on growth: The stock trades at 26.1x trailing but only 17.3x forward earnings, a 34% compression that implies the market expects substantial EPS growth toward the $6.36 consensus. The 1.10 PEG ratio suggests that growth is being priced at roughly fair value, and the 17.3x forward multiple sits about 20% below the ~22x large-cap industrial average.
  • Analyst consensus firmly bullish with reaffirmations: Seven Buy ratings, four Holds, and zero Sells produce a consensus 'buy' and a mean rating of 1.82. Citigroup reiterated Buy and RBC reiterated Outperform on October 30 following the Q3 print, and the $91.20 average target implies roughly 13.5% upside from $80.37.

Bearish

  • Thin free cash flow yield of 1.7%: TTM free cash flow of $153.7 million against a roughly $9.0 billion market cap implies an FCF yield of only about 1.7%. Cash generation is also lumpy — Q1 2026 operating cash flow was -$43.1 million on a $149.6 million working-capital drain before rebounding to $144.1 million in Q3.
  • Elevated leverage after acquisition and buybacks: Debt-to-equity stands at 0.80, with the $517.7 million Q2 acquisition funded partly by $428.6 million of new debt, alongside $50 million of Q3 buybacks and $62.7 million of debt repayment. Internal cash flow alone does not fully fund the growth-and-returns strategy, leaving less cushion if end markets soften.
  • Recent rally narrows risk/reward: The stock is up 13.97% in one month versus just 0.53% over three months, and at $80.37 it sits about 13% below the $92.41 52-week high. With the price already above the $75 low target, the 13.5% implied upside to the $91.20 average is moderate rather than compelling.
  • Margin trajectory is mixed, not linear: Gross margin moved from 37.1% in Q1 to 32.9% in Q2 to 33.5% in Q3, and operating margin slipped from 13.6% to 12.5% to 12.5%. The Q4 2025 quarter also produced a $29.0 million net loss (EPS -$0.23) on a $186.8 million negative other-expense line, showing earnings volatility outside core operations.

FLS Technical Analysis

Flowserve is in a choppy but net-positive intermediate uptrend: the stock is up 15.54% over the trailing year and 13.60% year-to-date, and at $80.37 it sits at roughly 58.8% of its 52-week range of $63.27 to $92.41 — closer to the midpoint than either extreme, which signals neither momentum overextension nor a falling-knife setup but rather a stock consolidating after a strong run. The 30.04% maximum drawdown from the 52-week high underscores that this has been a volatile advance rather than a smooth trend, and the price remains about 13% below the $92.41 peak, leaving overhead supply to absorb. Short-term momentum has re-accelerated sharply and is now diverging positively from the longer-term trend: the stock is up 13.97% over the past month versus a 0.53% gain over three months, meaning essentially all of the recent move occurred in the last four weeks. That 1-month surge of nearly 14 points against a flat 3-month base looks like a breakout from a multi-month base rather than a mean-reversion bounce, and it is corroborated by relative strength: FLS outperformed SPY by 18.96 percentage points over one month while SPY fell 4.99%, and by 13.53 points over six months. The 2.99% single-day gain on the latest session (from $78.04 to $80.37) on roughly 2.02 million shares suggests institutional accumulation rather than a low-volume drift. Key technical levels are the $92.41 52-week high as primary resistance and the $63.27 52-week low as the floor of the range, with the recent $67.76 October 22 low acting as nearer-term support; a decisive break above $92.41 would confirm a new leg higher and likely trigger momentum-fund buying, while a breakdown below $67.76 would invalidate the October breakout and refocus attention on the 52-week low. With a beta of 1.277, Flowserve is roughly 28% more volatile than the S&P 500, so position sizing should account for amplified drawdowns — the 30.04% max drawdown is a realistic stress-case guide, and the elevated 5.26 short ratio implies bears are still positioned, which can fuel squeezes on upside breaks but also signals genuine skepticism.

Beta

1.28

1.28x market volatility

Max Drawdown

-30.0%

Largest decline past year

52-Week Range

$63-$92

Price range past year

Annual Return

+22.2%

Cumulative gain past year

PeriodFLS ReturnS&P 500
1m+18.4%-2.3%
3m+2.8%-2.8%
6m+27.7%+2.1%
1y+22.2%+12.3%
ytd+17.5%+10.6%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

FLS Fundamental Analysis

Revenue is growing at a steady, modest pace with a clear sequential acceleration through 2026: Q3 2026 revenue of $1.238 billion rose 5.39% year-over-year from $1.174 billion in Q3 2025, and the quarterly progression from $1.068 billion in Q1 to $1.169 billion in Q2 to $1.238 billion in Q3 shows consistent sequential build. The mix is the key driver — aftermarket equipment contributed $697.5 million (56%) versus $540.3 million (44%) from original equipment, and the higher aftermarket weighting supports both revenue durability and margin quality since parts and service carry structurally better economics than lumpy, competitively bid OE projects. Full-year consensus revenue of approximately $5.98 billion implies continued mid-single-digit growth, which is respectable for a mature industrial but not a hyper-growth story; the investment case therefore hinges on margin and cash conversion rather than top-line acceleration. Profitability is solid and improving: Q3 2026 net income was $103.0 million on a 33.5% gross margin and 12.5% operating margin, with net margin of 8.3%, and the trailing-twelve-month figures of 34.6% gross margin, 13.0% operating margin, and 7.3% net margin confirm the company is comfortably profitable. The margin trajectory is mixed rather than linear — gross margin was 37.1% in Q1, 32.9% in Q2, and 33.5% in Q3, while operating margin improved from 13.6% to 12.5% to 12.5%, and the Q4 2025 quarter was an outlier loss of $29.0 million (EPS -$0.23) driven by a $186.8 million negative other-expense line, not operating deterioration, since that quarter's operating income was actually a healthy $193.5 million. Excluding that one-time item, the underlying earnings power is consistent, with diluted EPS of $0.64, $0.77, and $0.81 across the first three quarters of 2026, and the 15.8% ROE and 6.4% ROA are reasonable for a capital-intensive machinery manufacturer. The balance sheet is sound but not fortress-like: debt-to-equity of 0.80 and a current ratio of 2.03 provide adequate liquidity, cash stood at $742.1 million at Q3-end, and TTM free cash flow of $153.7 million against a $9.02 billion market cap implies a thin FCF yield of roughly 1.7%. Cash generation is lumpy — Q1 2026 operating cash flow was -$43.1 million on a $149.6 million working-capital drain, while Q3 rebounded to $144.1 million operating cash flow and $126.9 million FCF — and the company is actively deploying capital, with $50 million of Q3 buybacks, $28.0 million of dividends, $62.7 million of debt repayment, and a $517.7 million acquisition in Q2 funded partly by $428.6 million of new debt. The 17.8x price-to-cash-flow and 0.32 payout ratio indicate the dividend is well covered, but the heavy acquisition and buyback cadence means internal cash flow alone does not fully fund the strategy.

Quarterly Revenue

$1.2B

2026-09

Revenue YoY Growth

+5.4%

YoY Comparison

Gross Margin

33.5%

Latest Quarter

Free Cash Flow

$153658000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Aftermarket Equipment
Original Equipment

Open an Account, get $2 TSLA now!

Valuation Analysis: Is FLS Overvalued?

Because Flowserve is solidly profitable (Q3 2026 net income of $103.0 million; TTM EPS positive at $0.038 on a GAAP basis but $6.36 on a forward consensus basis), the PE ratio is the appropriate primary metric. The stock trades at 26.1x trailing earnings but only 17.3x forward earnings — a 34% compression that implies the market expects substantial EPS growth, consistent with consensus 2027 EPS of $6.36 versus the current run-rate, and the 1.10 PEG ratio suggests that growth is being priced at roughly fair value rather than at a premium. The gap between trailing and forward multiples is the single most important valuation signal here: investors are paying a mid-20s multiple for today's earnings but a high-teens multiple for next year's, which leaves less room for execution disappointment than the trailing figure alone would suggest. On relative valuation, Flowserve screens cheap versus its own history but not versus the broad market: its 1.91x price-to-sales and 2.51x EV/sales are modest for an industrial with 34.6% gross margins, and its 14.3x EV/EBITDA is reasonable for a machinery company, while the 4.12x price-to-book reflects a business with meaningful tangible assets. The 17.3x forward PE compares favorably to the roughly 22x average for large-cap industrials, implying a discount of approximately 20%, which is defensible given Flowserve's mid-single-digit growth rate, 7.3% net margin, and cyclical end-market exposure to oil and gas and chemicals — this is a value-priced industrial, not a premium-compounder multiple. The 1.2% dividend yield and 0.32 payout ratio add a modest income cushion but are not the thesis. Historically, Flowserve's PE has ranged widely — from 7.9x in Q3 2025 (inflated by a one-time gain) and 21-24x through most of 2024-2025 to 26-29x in the most recent quarters — so the current 26.1x trailing multiple sits near the top of its multi-year band, while the 17.3x forward multiple sits closer to the middle. The price-to-sales ratio of 1.91x is actually near the low end of its historical range (which ran 3.6x-8.8x over the past several years, though those figures reflect a different share count and price basis), and the 4.12x P/B is above the 2.2x-3.8x band of 2021-2024. The read-through is that the market is pricing in optimistic but not heroic expectations: the trailing multiple is elevated because earnings are temporarily depressed by the Q4 2025 charge and acquisition-related costs, and the forward multiple normalizes once those roll off.

PE

26.1x

Latest Quarter

vs. Historical

Mid-Range

5-Year PE Range 21x~29x

vs. Industry Avg

30.2x

Industry PE ~30.2x*

EV/EBITDA

14.3x

Enterprise Value Multiple

Investment Risk Disclosure

Financial and operational risks center on cash conversion and leverage. TTM free cash flow of $153.7 million against a roughly $9.0 billion market cap yields only about 1.7%, and Q1 2026 operating cash flow was -$43.1 million on a $149.6 million working-capital drain, showing that cash generation can swing sharply quarter to quarter. Debt-to-equity of 0.80 reflects the $517.7 million Q2 acquisition funded partly by $428.6 million of new debt, and with $50 million of Q3 buybacks and $28.0 million of dividends also competing for capital, the balance sheet has limited slack. Revenue is also concentrated in cyclical end markets — oil and gas, chemicals, and power — and gross margin already oscillated from 37.1% in Q1 to 32.9% in Q2 to 33.5% in Q3, so a demand pause would pressure both the top line and the margin story simultaneously.

Market and competitive risks are dominated by valuation sensitivity and cyclicality. At 26.1x trailing earnings the stock sits near the top of its multi-year band, and the 17.3x forward multiple depends on delivering the $6.36 consensus EPS; any shortfall forces multiple compression on top of an earnings miss. The 1.277 beta means Flowserve is roughly 28% more volatile than the S&P 500, amplifying sector rotation out of industrials, and the 5.26 short ratio signals genuine skepticism that can accelerate declines. The recent Zacks commentary flagged mixed divisional performance and recent stock weakness as limiting near-term upside, and TD Cowen's June 24 downgrade to Hold shows at least one house has stepped aside on valuation.

In a worst-case scenario, oil and gas capex softens, aftermarket orders decelerate, the Q2 acquisition integration disappoints, and margins fail to expand — forcing analysts toward the $75 low target while the multiple compresses toward the low end of its historical band. From the current $80.37, a move to the $75 low target is about -6.7%, while a retest of the $63.27 52-week low would be roughly -21%. The 30.04% maximum drawdown is a realistic stress guide for a full cyclical downturn, implying an investor could lose approximately 30% from current levels in an adverse scenario.

FAQ

The most severe risk is financial and operational: TTM free cash flow of $153.7 million yields only about 1.7%, and Q1 2026 operating cash flow was -$43.1 million on a $149.6 million working-capital drain, showing cash generation can swing sharply. Second is leverage and capital allocation — debt-to-equity of 0.80 reflects the $517.7 million Q2 acquisition funded partly by $428.6 million of new debt, competing with $50 million of Q3 buybacks and $28.0 million of dividends for limited capital. Third is valuation and cyclicality: at 26.1x trailing earnings near the top of its multi-year band, any shortfall against the $6.36 consensus EPS forces multiple compression on top of an earnings miss, and the 1.277 beta makes the stock roughly 28% more volatile than the S&P 500 amid sector rotation. Fourth is company-specific execution — gross margin oscillated 37.1% → 32.9% → 33.5% across Q1-Q3 2026 and operating margin slipped from 13.6% to 12.5%, while the 5.26 short ratio and TD Cowen's June 24 downgrade to Hold signal genuine skepticism that could accelerate declines.

The 12-month forecast splits into three scenarios. The base case (55% probability) targets $88-$93, assuming roughly $6.36 in 2027 EPS on mid-single-digit revenue growth near $5.98 billion, operating margins holding at 12.5-13.5%, and a multiple near 14-14.5x forward earnings — consistent with the $91.20 average target and implying roughly 10-16% total return including the 1.2% dividend yield. The bull case (25% probability) targets $95-$100, requiring operating margins to push toward the mid-teens, aftermarket mix to hold at or above 56%, FCF conversion to normalize, and a re-rating to ~15-16x forward earnings, matching the $100 analyst high target. The bear case (20% probability) targets $63.27-$75, where oil and gas and chemical capex soften, aftermarket orders decelerate, and the acquisition integration disappoints, forcing earnings toward the $6.31 low end with no multiple expansion. The base case is most likely, and its key assumption is that margins hold near 12.5-13.5% and the multiple stays near 14-14.5x forward earnings.

FLS looks fairly valued to modestly undervalued on a forward basis but fully valued relative to its own recent trading range. The stock trades at 26.1x trailing earnings but only 17.3x forward earnings — a 34% compression implying the market expects substantial EPS growth toward the $6.36 consensus — and the 1.10 PEG suggests that growth is priced at roughly fair value. Relative to peers, the 17.3x forward multiple is about 20% below the ~22x large-cap industrial average, a discount defensible given mid-single-digit growth, a 7.3% net margin, and cyclical end-market exposure. On other metrics, the 1.91x price-to-sales and 2.51x EV/sales are modest for an industrial with 34.6% gross margins, and the 14.3x EV/EBITDA is reasonable for a machinery company. The read-through is that the market is pricing in optimistic but not heroic expectations: the elevated trailing multiple reflects temporarily depressed earnings from the Q4 2025 charge and acquisition costs, while the forward multiple normalizes once those roll off.

From a risk/reward standpoint, FLS is a reasonable but not compelling buy at $80.37. The upside to the $91.20 average analyst target is about 13.5%, backed by 7 Buy ratings, 4 Holds, and zero Sells (mean rating 1.82), and the 17.3x forward multiple sits roughly 20% below the ~22x large-cap industrial average with a fair 1.10 PEG. However, the stock has already rallied 13.97% in one month and now trades above the $75 analyst low target, narrowing the margin of safety, while the thin 1.7% FCF yield and 0.80 debt-to-equity after the $517.7 million acquisition limit the downside cushion. The biggest downside risk is a cyclical pullback toward the $63.27 52-week low, roughly -21%, or the 30.04% historical max drawdown in a fuller downturn. It is a good buy primarily for patient, value-oriented investors willing to accumulate on weakness toward $75, or for those who see operating margin pushing from 12.5% toward the mid-teens; it is less attractive for momentum buyers chasing the recent move.

FLS is better suited to a medium-to-long-term holding period of at least 12-18 months than to short-term trading. It is a mature, mid-cap industrial with mid-single-digit revenue growth (Q3 +5.39% year-over-year), a modest 1.2% dividend yield with a well-covered 0.32 payout ratio, and a 56% aftermarket mix that provides recurring revenue durability — characteristics that reward patience rather than momentum timing. The 1.277 beta means the stock is roughly 28% more volatile than the S&P 500, and the 30.04% maximum drawdown shows it can endure sharp swings, so short-term traders face amplified downside without a clear near-term catalyst beyond the Q4 2026 earnings print. Earnings visibility is moderate: the $6.36 consensus 2027 EPS is reasonably anchored, but cash conversion is lumpy (Q1 2026 operating cash flow of -$43.1 million versus $144.1 million in Q3) and the margin trajectory is mixed. A concrete suggested minimum holding period is 12-18 months, allowing time for margin expansion and acquisition synergies to materialize and for the stock to work toward the $91.20 average target.